Episode Details
Back to Episodes
ThePrintPod: India’s draft guidelines on biosimilar drugs can make treatments more accessible, affordable
Episode 8640
Published 5 months, 2 weeks ago
Description
Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.